Teva Pharmaceutical Industries Limited Financials

Market Capitalization ₪66.28 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	2940.00
Forward PE	20.86
Price to Sales TTM	₪3.99
Price to Book MRQ	₪1058.42
Enterprise to Revenue	4.85
Enterprise to EBITDA	18.11

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-7.74%
Operating Margin	18.22%
Return on Assets TTM	5.27%
Return on Equity TTM	-19.11%

Income Statement

Revenue TTM	₪16,544,000,000
Revenue per Share TTM	₪14.64
Quarterly Revenue Growth	1.90%
Gross Profit TTM	₪8,064,000,000
EBITDA	₪4,402,000,000
Net Income to Common TTM	₪-1,639,000,000
Diluted EPS TTM	₪-3.87
Quarterly Earnings Growth YoY	1.89%

Balance Sheet

Total Cash MRQ	₪529,000,000
Total Cash per Share MRQ	₪1.48
Total Debt MRQ	₪
Total Debt to Equity MRQ	270.20
Current Ratio MRQ	1.03
Book Value per Share MRQ	₪5.46

Cash Flow

Operating Cash Flow TTM	₪-1,286,000,000
Levered Free Cash Flow TTM	₪5,588,000,000

TEVA Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,133,838,689
Float Shares	1,141,339,752
Avg 10 Volume	1,601,610
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.43%
% Held by Institutions	6.95%

Stock Price Summary

Beta	0.61
Fifty Two Week Low	₪4865.00
Fifty Two Week High	₪8431.00
Fifty Two Week Change	-6.62%
Day 50 MA	₪5998.04
Day 200 MA	₪6354.44

Dividends and Splits

Forward Annual Dividend Rate	₪114.18
Forward Annual Dividend Yield	1.99%
Trailing Annual Dividend Rate	₪285.44
Trailing Annual Dividend Yield	4.97%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date	2017-11-28
Last Split Factor
Last Split Date	2004-06-27